| [1] Eden A, Gaudet F, Waghmare A, et al. Chromosomal instability and tumors promoted by DNA hypomethylation[J]. Science,2003,300(5618): 455.[2] Feinberg A P, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer[J]. Nat Rev Genet,2006, 7(1): 21-33.[3] Jones P A, Baylin S B. The fundamental role of epigenetic events in cancer[J]. Nat Rev Genet,2002, 3(6): 415-428.[4] Noushmehr H, Weisenberger D J, Diefes K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma[J]. Cancer Cell, 2010,17(5): 510-522.[5] Cadieux B, Ching T T, VandenBerg S R, et al. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation[J]. Cancer Res, 2006,66(17): 8469-8476.[6] Le Gallo M, O'Hara A J, Rudd M L, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes[J]. Nat Genet, 2012, 44(12): 1310-1315.[7] Ley T J, Ding L, Walter M J, et al. DNMT3A mutations in acute myeloid leukemia[J]. N Engl J Med,2010, 363(25): 2424-2433.[8] Kwon Y J, Lee S J, Koh J S, et al. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer[J]. J Thorac Oncol,2012, 7(1): 20-33.[9] Foltz G, Yoon J G, Lee H, et al. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis[J]. Oncogene,2009, 28(29): 2667-2677.[10] Louis D N, Ohgaki H, Wiestler O D, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007,114(2):97-109.[11] Feinberg A P, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts[J]. Nature,1983, 301(5895): 89-92.[12] Wu X, Rauch T A, Zhong X, et al. CpG island hypermethylation in human astrocytomas[J]. Cancer Res,2010, 70(7): 2718-2727.[13] Laffaire J, Everhard S, Idbaih A, et al. Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis[J]. Neuro Oncol,2011,13(1): 84-98.[14] Pennisi E. History of science. The case of the midwife toad: fraud or epigenetics[J].Science,2009,325(5945): 1194-1195.[15] Etcheverry A, Aubry M, de Tayrac M, et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome[J]. BMC Genomics,2010,11: 701.[16] Liu K, Wang Y F, Cantemir C, et al. Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo[J]. Mol Cell Biol,2003,23(8): 2709-2719.[17] Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases[J]. Cell Mol Life Sci, 2004,61(19－20): 2571-2587.[18] Robertson K D, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors[J]. Nucleic Acids Res, 1999, 27(11): 2291-2298.[19] Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases[J]. Nat Genet,1998, 19(3): 219-220.[20] Ostler K R, Davis E M, Payne S L, et al. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins[J]. Oncogene,2007,26(38): 5553-5563.[21] Suetake I, Shinozaki F, Miyagawa J, et al. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction[J]. J Biol Chem,2004, 279(26): 27816-27823. |
